Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience

Yotam Levin; Noa Madar Balakirski; Yoseph Caraco; Eytan Ben-Ami; Jacob Atsmon; Hadar Marcus

doi:10.1016/j.vaccine.2021.04.017

Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience

Yotam Levin, Noa Madar Balakirski, Yoseph Caraco, Eytan Ben-Ami, Jacob Atsmon, Hadar Marcus^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Original language	English
Pages (from-to)	2821-2823
Number of pages	3
Journal	Vaccine
Volume	39
Issue number	21
DOIs	https://doi.org/10.1016/j.vaccine.2021.04.017
State	Published - 18 May 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2021.04.017

Cite this

@article{505bccce5b5447008d1cb610107dfa59,

title = "Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience",

author = "Yotam Levin and Balakirski, {Noa Madar} and Yoseph Caraco and Eytan Ben-Ami and Jacob Atsmon and Hadar Marcus",

year = "2021",

month = may,

day = "18",

doi = "10.1016/j.vaccine.2021.04.017",

language = "אנגלית",

volume = "39",

pages = "2821--2823",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "21",

}

TY - JOUR

T1 - Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience

AU - Levin, Yotam

AU - Balakirski, Noa Madar

AU - Caraco, Yoseph

AU - Ben-Ami, Eytan

AU - Atsmon, Jacob

AU - Marcus, Hadar

PY - 2021/5/18

Y1 - 2021/5/18

UR - http://www.scopus.com/inward/record.url?scp=85105260853&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2021.04.017

DO - 10.1016/j.vaccine.2021.04.017

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 33896663

AN - SCOPUS:85105260853

SN - 0264-410X

VL - 39

SP - 2821

EP - 2823

JO - Vaccine

JF - Vaccine

IS - 21

ER -

Ethics and execution of developing a 2nd wave COVID vaccine – Our interim phase I/II VSV-SARS-CoV2 vaccine experience

UN SDGs

Access to Document

Other files and links

Cite this